| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Colm M P O'Tuathaigh, Ilse Gantois, John L Waddingto. Genetic dissection of the psychotomimetic effects of cannabinoid exposure. Progress in neuro-psychopharmacology & biological psychiatry. vol 52. 2014-12-12. PMID:24239593. |
cannabis use is an established risk factor for the development of schizophrenia and related psychotic disorders. |
2014-12-12 |
2023-08-12 |
human |
| Matthijs G Bossong, J Martijn Jansma, Sagnik Bhattacharyya, Nick F Ramse. Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC). Progress in neuro-psychopharmacology & biological psychiatry. vol 52. 2014-12-12. PMID:24380726. |
role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (thc). |
2014-12-12 |
2023-08-12 |
human |
| Matthijs G Bossong, J Martijn Jansma, Sagnik Bhattacharyya, Nick F Ramse. Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC). Progress in neuro-psychopharmacology & biological psychiatry. vol 52. 2014-12-12. PMID:24380726. |
here we review human studies that investigated acute effects of cannabis or ∆9-tetrahydrocannabinol (thc) on brain functions that are implicated in schizophrenia. |
2014-12-12 |
2023-08-12 |
human |
| Thomas Schnell, Dagmar Koethe, Anna Krasnianski, Stefanie Gairing, Knut Schnell, Jörg Daumann, Euphrosyne Gouzoulis-Mayfran. Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study. The American journal on addictions. vol 23. issue 3. 2014-12-10. PMID:24628830. |
ziprasidone versus clozapine in the treatment of dually diagnosed (dd) patients with schizophrenia and cannabis use disorders: a randomized study. |
2014-12-10 |
2023-08-12 |
Not clear |
| Palmiero Monteleone, Carmela Di Filippo, Michele Fabrazzo, Walter Milano, Vassilis Martiadis, Giulio Corrivetti, Alessio Maria Monteleone, Mario Ma. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. Psychiatry research. vol 215. issue 2. 2014-12-03. PMID:24388728. |
flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. |
2014-12-03 |
2023-08-12 |
Not clear |
| Palmiero Monteleone, Carmela Di Filippo, Michele Fabrazzo, Walter Milano, Vassilis Martiadis, Giulio Corrivetti, Alessio Maria Monteleone, Mario Ma. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. Psychiatry research. vol 215. issue 2. 2014-12-03. PMID:24388728. |
cannabis may play a causal role in the onset of some schizophrenia cases; however, the biological vulnerability that predisposes some individuals to develop schizophrenia after exposure to cannabis is not known. |
2014-12-03 |
2023-08-12 |
Not clear |
| Palmiero Monteleone, Carmela Di Filippo, Michele Fabrazzo, Walter Milano, Vassilis Martiadis, Giulio Corrivetti, Alessio Maria Monteleone, Mario Ma. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. Psychiatry research. vol 215. issue 2. 2014-12-03. PMID:24388728. |
therefore, we investigated the saliva cortisol awakening response (car) of 16 patients with schizophrenia onset after the exposure to cannabis (can+) as compared to 12 patients with schizophrenia onset without cannabis exposure (can-) and to 15 healthy controls. |
2014-12-03 |
2023-08-12 |
Not clear |
| Palmiero Monteleone, Carmela Di Filippo, Michele Fabrazzo, Walter Milano, Vassilis Martiadis, Giulio Corrivetti, Alessio Maria Monteleone, Mario Ma. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. Psychiatry research. vol 215. issue 2. 2014-12-03. PMID:24388728. |
further studies need to clarify whether this hpa dysregulation is a part of the biological background underlying the increased risk to schizophrenia after exposure to cannabis. |
2014-12-03 |
2023-08-12 |
Not clear |
| Lynn E Delis. Re: Caution urged in interpreting a negative study of cannabis use and schizophrenia: a response to Dr. Christine Miller. Schizophrenia research. vol 154. issue 1-3. 2014-11-26. PMID:24630137. |
re: caution urged in interpreting a negative study of cannabis use and schizophrenia: a response to dr. christine miller. |
2014-11-26 |
2023-08-12 |
Not clear |
| Christine L Mille. Caution urged in interpreting a negative study of cannabis use and schizophrenia. Schizophrenia research. vol 154. issue 1-3. 2014-11-26. PMID:24636304. |
caution urged in interpreting a negative study of cannabis use and schizophrenia. |
2014-11-26 |
2023-08-12 |
Not clear |
| Maarten Smeerdijk, René Keet, Lieuwe de Haan, Christine Barrowclough, Don Linszen, Gerard Schipper. Feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use. Journal of substance abuse treatment. vol 46. issue 3. 2014-11-12. PMID:24157087. |
feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use. |
2014-11-12 |
2023-08-12 |
Not clear |
| Maarten Smeerdijk, René Keet, Lieuwe de Haan, Christine Barrowclough, Don Linszen, Gerard Schipper. Feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use. Journal of substance abuse treatment. vol 46. issue 3. 2014-11-12. PMID:24157087. |
this study examined the feasibility of providing motivational interviewing (mi) training to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use. |
2014-11-12 |
2023-08-12 |
Not clear |
| Arnar Jan Jonsson, Hera Birgisdottir, Engilbert Sigurdsso. [Does the use of cannabis increase the risk for psychosis and the development of schizophrenia?]. Laeknabladid. vol 100. issue 9. 2014-10-14. PMID:25242813. |
[does the use of cannabis increase the risk for psychosis and the development of schizophrenia?]. |
2014-10-14 |
2023-08-13 |
Not clear |
| Arnar Jan Jonsson, Hera Birgisdottir, Engilbert Sigurdsso. [Does the use of cannabis increase the risk for psychosis and the development of schizophrenia?]. Laeknabladid. vol 100. issue 9. 2014-10-14. PMID:25242813. |
over the past 30 years evidence has been growing that cannabis use increases the risk for psychosis which could develop into schizophrenia in a proportion of cases. |
2014-10-14 |
2023-08-13 |
Not clear |
| Arnar Jan Jonsson, Hera Birgisdottir, Engilbert Sigurdsso. [Does the use of cannabis increase the risk for psychosis and the development of schizophrenia?]. Laeknabladid. vol 100. issue 9. 2014-10-14. PMID:25242813. |
when the results of these studies are taken together they unambiguously support that cannabis use is an independent risk factor for psychosis and may also give rise to chronic psychotic disorders like schizophrenia. |
2014-10-14 |
2023-08-13 |
Not clear |
| Anthony James, Christine James, Thomas Thwaite. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry research. vol 214. issue 3. 2014-10-10. PMID:24139960. |
the brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. |
2014-10-10 |
2023-08-12 |
Not clear |
| Anthony James, Christine James, Thomas Thwaite. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry research. vol 214. issue 3. 2014-10-10. PMID:24139960. |
the studies of cannabis use in adolescent-onset schizophrenia (aos) differ, with one study pointing to extensive gm and wm changes. |
2014-10-10 |
2023-08-12 |
Not clear |
| Anthony James, Christine James, Thomas Thwaite. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry research. vol 214. issue 3. 2014-10-10. PMID:24139960. |
as in adult schizophrenia cognition does not appear to be adversely affected in aos following cannabis use. |
2014-10-10 |
2023-08-12 |
Not clear |
| Erica Zamberletti, Sarah Beggiato, Luca Steardo, Pamela Prini, Tiziana Antonelli, Luca Ferraro, Tiziana Rubino, Daniela Parolar. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. Neurobiology of disease. vol 63. 2014-09-19. PMID:24200867. |
although several findings indicate an association between adolescent cannabis abuse and the risk to develop schizophrenia later in life, the evidence for a causal relationship is still inconclusive. |
2014-09-19 |
2023-08-12 |
rat |
| János M Réthelyi, Judit Benkovits, István Bitte. Genes and environments in schizophrenia: The different pieces of a manifold puzzle. Neuroscience and biobehavioral reviews. vol 37. issue 10 Pt 1. 2014-09-07. PMID:23628741. |
epidemiologically proven risk factors, such as prenatal infection, obstetric complications, urbanicity, cannabis, and trauma have been demonstrated to interact with genetic risk, giving rise to higher prevalence rates or more severe symptomatology in individuals with direct or indirect genetic predisposition for schizophrenia. |
2014-09-07 |
2023-08-12 |
Not clear |